User-agent: Twitterbot/1.0
Allow: /programs/medical-industry-feature-live-lunch-and-learn/irritable-male-syndrome/27
Allow: /live-events/mod-live-2025-virtual-clinical-optometry-symposium/39947
Allow: /programs/modern-optometry/ocular-surface-disease-latest-innovations-in-dry-eye-and-meibomian-gland-dysfunction/49031
Allow: /empower-business-specialty-care-optometric-series/septemberoctober-2026-supplement/the-new-pharmacotherapy-of-dry-eye-and-meibomian-gland-dysfunction-2/70186
Allow: /empower-business-specialty-care-optometric-series/septemberoctober-2026-supplement/combination-therapy-for-ocular-surface-disease-a-framework-for-modern-practice/70187
Sitemap: https://modernod.com/sitemap.xml
User-agent: *
Disallow: /accounts/reset*
Disallow: /accounts/password_reset*
Disallow: /playlist/top
Disallow: /profiles
Disallow: /profiles/peers/in-common*
Allow: /profiles/*/*/biography/
Disallow: /messages/send_to*
Disallow: /segment/*/
Disallow: /programs/medical-industry-feature-live-lunch-and-learn/irritable-male-syndrome/27
Disallow: /mod-issues/2021-jan-feb-insert3/supra-threshold-testing-is-it-time-to-rethink-perimetry/38174
Disallow: /mod-issues/2021-jan-feb-insert3/supra-threshold-testing-is-it-time-to-rethink-perimetry-1/38194
Disallow: /mod-issues/2021-july-aug-insert3/updates-in-keratoconus-management-and-the-fda-approved-ilink-cross-linking-procedure/38254
Disallow: /mod-issues/2021-july-aug-supplement4/neurotrophic-keratitis-early-intervention-is-key-1/38280
Disallow: /mod-issues/2021-july-aug-supplement4/keratoconus-testing-consensus-statement/38281
Disallow: /live-events/mod-live-2025-virtual-clinical-optometry-symposium/39947
Disallow: /programs/modern-optometry/ocular-surface-disease-latest-innovations-in-dry-eye-and-meibomian-gland-dysfunction/49031
Disallow: /empower-business-specialty-care-optometric-series/septemberoctober-2026-supplement/the-new-pharmacotherapy-of-dry-eye-and-meibomian-gland-dysfunction-2/70186
Disallow: /empower-business-specialty-care-optometric-series/septemberoctober-2026-supplement/combination-therapy-for-ocular-surface-disease-a-framework-for-modern-practice/70187
Sitemap: https://modernod.com/sitemap.xml